SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2025

Dec 17, 2025

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in

==> picture [180 x 70] intentionally omitted <==

December 17, 2025

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051

Scrip Code: 541540, 890202

Symbol: SOLARA, SOLARAPP1

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of Board Meeting dated December 17, 2025

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015(‘ SEBI Listing Regulations ’), this is to inform you that the Board of Directors of the Company based on the recommendation of the Nomination and Remuneration Committee, at its meeting held today i.e. December 17, 2025, inter- alia, transacted and approved the appointment of Mr. Mohanraj S(DIN: 08420411) as an Additional - Executive Director and Whole -Time Director for a period of 3 years with effect from January 1, 2026 subject to approval of the Shareholders of the Company.

Further, in terms of BSE Circular bearing Reference No. LIST/COMP/14/2018-19 and NSE Circular bearing Reference No. NSE/CML/2018/24 dated June 20, 2018, we wish to confirm that Mr. Mohanraj S is not debarred from accessing capital markets and /or restrained from holding the office of Director by virtue of any order of the Securities and Exchange Board of India ( “SEBI ”) or any other such authority.

The information in regard to the abovementioned on proposal for Change in Directors/ Key Managerial Personnel and the in terms of Regulation 30 read with Schedule III - Para A (7) of Part A and of the SEBI Listing Regulations (as applicable) and SEBI Circular bearing Ref. No. CIR/CFD/CMD/4/2015 dated September 09, 2015 read with Circular Ref. No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and SEBI Master Circular Ref No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed herewith as Annexure – I.

Brief Profile of Mr. Mohanraj S is enclosed herewith in Annexure – IA .

We request you to take the same on record and the same be treated as compliance under the applicable provisions of the SEBI Listing Regulations, as amended.

The Board Meeting commenced at 10.15 AM and concluded at 10.25 AM.

Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited

POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2025.12.17 10:43:38 +05'30' Pooja Jaya Kumar Company Secretary & Compliance Officer (Membership No. A57415) Encl.: As above

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636

Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91- 22-20870033

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in

==> picture [180 x 70] intentionally omitted <==

Annexure – I

Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/ 2023/123 dated July 13, 2023 read with Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

==> picture [448 x 226] intentionally omitted <==

----- Start of picture text -----

Sr. No. Particulars Appointment of Mr. Mohanraj S
1. Reason for Change Appointment of Mr. Mohanraj S, as an Additional Director
– Executive Director and Whole Time Director of the
Company, subject to the approval of shareholders at the
ensuing Postal Ballot.
2. Date of appointment (as Appointed with effect from January 01, 2026, for a period of
applicable) & term of three (3) years
appointment
3. Brief Profile Enclosed herewith as Annexure – IA
4. Disclosure of relationships Mr. Mohanraj S is not related to any of the Directors
between directors or Key Managerial Personnel of the Company.
----- End of picture text -----

For Solara Active Pharma Sciences Limited

POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2025.12.17 10:44:05 +05'30' Pooja Jaya Kumar Company Secretary & Compliance Officer (Membership No. A57415)

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91- 22-20870033

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in

==> picture [180 x 70] intentionally omitted <==

Annexure – IA

==> picture [461 x 17] intentionally omitted <==

----- Start of picture text -----

Name Profile
----- End of picture text -----

Name Profile	Name Profile
Mr. Mohanraj S- Additional Executive Director and Whole-Time Director	Mr. Mohanraj S is a seasoned executive leader with over three decades of experience across the Pharmaceutical, Biotech, Defence & Aerospace, Engineering, Apparel, and Media sectors. He brings deep expertise in industrial relations strategy, workforce governance, statutory and regulatory compliance, and organizational leadership, with particular distinction in managing complex IR environments. Professionally qualified in employee and industrial relations, Mr. Mohanraj has successfully negotiated and signed 7–8 long-term union settlements, predominantly in the pharmaceutical industry, and also across defence and aerospace organizations. His experience includes managing multiple unions simultaneously, navigating highly challenging IR situations, and maintaining industrial stability in unionized environments. He has worked closely with internal leadership teams as well as external stakeholders, including senior union leaders and regulatory authorities, to achieve sustainable and compliant outcomes. Over a career spanning more than 30 years, he has overseen compliance under a wide range of labour and employment statutes, including environmental, health, and safety (EHS) regulations, across multi-location manufacturing units. He has held senior leadership roles at organizations such as Mylan Laboratories, The Manipal Group, and Tata Advanced Materials, where he was recognized for his strategic judgment, institutional leadership, and ability to align workforce frameworks with business and operational priorities. Mr. Mohanraj holds a Master’s degree in Social Work from the University of Madras and a Bachelor’s degree in Behavioural Sciences from St. Joseph’s College, Bengaluru. He is a certified ISO auditor and has been acknowledged for his contributions to industrial relations excellence and corporate responsibility initiatives. He is on the Board of Studies for Industrial Relations at St. Joseph’s University over 2 decades, contributingto curriculum development and industry–academia collaboration.

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91- 22-20870033